FDA.reportPublic FDA data

Application 012365

Type
NDA
Sponsor
MEDA PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
005SOMA COMPOUNDASPIRIN; CARISOPRODOLTABLET;ORAL325MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
324SUPPL2013-02-04
10802SUPPL2013-02-01
323SUPPL2010-01-06
33083SUPPL2009-11-17
33082SUPPL2009-04-03
12004SUPPL2009-04-03